Cyclosporine regimens in plaque psoriasis: An overview with special emphasis on dose, duration, and old and new treatment approaches

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Colombo, M D ^a,b   Cassano, N ^c   Bellia, G ^a   Vena, G A ^c  

^a Medical Department   (Italy)

^b Marchesi Hospital   (Italy)

^c Dermatology and Venereology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CALCIPOTRIOL; CYCLOSPORIN A; DITHRANOL; EFALIZUMAB; ETANERCEPT; ETRETIN; METHOTREXATE; PLACEBO; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

BODY WEIGHT; COMPARATIVE STUDY; DISEASE SEVERITY; FOLLOW UP; HUMAN; HYPERTENSIVE CRISIS; MONOTHERAPY; PSORIASIS VULGARIS; QUALITY OF LIFE; REMISSION; RETROSPECTIVE STUDY; REVIEW; TREATMENT DURATION; DOSE RESPONSE; PSORIASIS;

CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PSORIASIS;

EID: 84881423833     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/805705     Document Type: Review

References (82)

1. Stern R. S., Nijsten T., Feldman S. R., Margolis D. J., Rolstad T., Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. Journal of Investigative Dermatology Symposium Proceedings 2004 9 2 136 139 2-s2.0-1842555395 10.1046/j.1087-0024.2003.09102.x (Pubitemid 38457271)
2. Raho G., Koleva D. M., Garattini L., Naldi L., The burden of moderate to severe psoriasis: an overview. Pharmacoeconomics 2012 30 11 1005 1013
3. Finzi A., Colombo D., Caputo A., Andreassi L., Chimenti S., Vena G., Simoni L., Sgarbi S., Giannetti A., Bianchi B., Gallo G., Baldo B., Flori F., Zane Z., Di Nuzzo D. N., Catteneo C., Altiero A., Lo Schiavo L. S., Kokelj K., Masci M., Locatelli L., Bardazzi B., Coppini C., Reseghetti R., Amato A., Lacarrubba L., Manfrè M., Cavallaro C., Soro S., Schena S., Vena V., Montesu M., Bonvicino B., Zucca Z., Garcovich G., Bongiorno B., Giuliano G., Zavattaro Z., Rossini R., Loconsole L., Simonetti S., Gallo G., Favot F., Repetto R., Difonzo D., Calvieri C., Cecchetti C., Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study. Journal of the European Academy of Dermatology and Venereology 2007 21 9 1161 1169 2-s2.0-34548708464 10.1111/j.1468-3083.2007.02079.x (Pubitemid 47423402)
4. Mueller W., Herrmann B., Cyclosporin A for psoriasis. New England Journal of Medicine 1979 301 10 555 2-s2.0-0018321051 (Pubitemid 9258270)
5. Cassano N., Colombo D., Vena G. A., Linee guida al trattamento con ciclosporina A. Stato dell'arte. Giornale Italiano di Dermatologia e Venereologia 2001 136 6 463 470 (Pubitemid 34225451)
6. Ho V. C., Griffiths C. E. M., Albrecht G., Vanaclocha F., León-Dorantes G., Atakan N., Reitamo S., Johannesson A., Mørk N. J., Clarke P., Pfister P., Paul C., Intermittent short courses of cyclosporin (Neoral) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. British Journal of Dermatology 1999 141 2 283 291 2-s2.0-0032792540 10.1046/j.1365-2133.1999.02977.x (Pubitemid 29397997)
7. Ellis C. N., Fradin M. S., Messana J. M., Brown M. D., Siegel M. T., Hartley A. H., Rocher L. L., Wheeler S., Hamilton T. A., Parish T. G., Ellis-Madu M., Duell E., Annesley T. M., Cooper K. D., Voorhees J. J., Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial. New England Journal of Medicine 1991 324 5 277 284 2-s2.0-0026013163
8. Rosmarin D. M., Lebwohl M., Elewski B. E., Gottlieb A. B., Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference. Journal of the American Academy of Dermatology 2010 62 5 838 853 2-s2.0-77950596138 10.1016/j.jaad.2009.05.017
9. Meffert H., Bräutigam M., Färber L., Weidinger G., Low-dose (1.25 mg/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profile. Acta Dermato-Venereologica 1997 77 2 137 141 2-s2.0-0030921333 (Pubitemid 27201992)
10. Thaçi D., Bräutigam M., Kaufmann R., Weidinger G., Paul C., Christophers E., Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study. Dermatology 2002 205 4 383 388 2-s2.0-0036432857 10.1159/000066425 (Pubitemid 35356767)
11. Christophers E., Mrowietz U., Henneicke H.-H., Farber L., Welzel D., Cyclosporine in psoriasis: a multicenter dose-finding study in severe plaque psoriasis. Journal of the American Academy of Dermatology 1992 26 1 86 90 2-s2.0-0026508771
12. Laburte C., Grossman R., Abi-Rached J., Abeywickrama K. H., Dubertret L., Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long- term treatment of chronic severe plaque psoriasis. British Journal of Dermatology 1994 130 3 366 375 2-s2.0-0028291307 10.1111/j.1365-2133.1994.tb02935.x (Pubitemid 24204648)
13. Mahrle G., Schulze H.-J., Farber L., Weidinger G., Steigleder G. K., Hums H., Prifert P., Albrecht A., Borchers B., Kreysel K., Lindenblatt L., Vogel V., Koschinski K., Hage dorn H. D., Sattler S., Goring G., Panzner P., Schubert S., Lindner L., Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. Journal of the American Academy of Dermatology 1995 32 1 78 88 2-s2.0-0028843204 10.1016/0190-9622(95) 90189-2
14. Koo J., Abrams B., Albrecht G., Altmeyer P., Bahmer F. A., Belaich S., Berth-Jones J., Bjerke J. R., Bos J. D., Braathen L., Burg G., Burrows D., Claudy A., Drake L. A., Dubertret L., Engst R., Ettelt M. I., Frenk E., Frosch P. J., Ganslandt J., Goos M., Graham-Brown R. A. C., Guilhou J. J., Haustein U. F., Helland S., Hutchinson K., Jacobi H., Jung E. G., Kang S., Kind P., Knop J., Lowe N. J., Luger T., Mahrle G., Marks R., Meffert H., Meyer J., Mørk N. J., Mrowietz U., Neumann H. A. M., Olsen E. A., Rogers S., Ruzicka T., Schmidt A.-G., Schöpf E., Shupack J. L., Starink T. M., Tio D., Van Vloten W. A., Vermeer B. J., Wollina U., A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. British Journal of Dermatology 1998 139 1 88 95 2-s2.0-0031847245 10.1046/j.1365-2133.1998.02319.x (Pubitemid 28338069)
15. Timonen P., Friend D., Abeywickrama K., Laburte C., Von Graffenried B., Feutren G., Efficacy of low-dose cyclosporin A in sporiasis: results of dose-finding studies. British Journal of Dermatology 1990 122 36 33 39 2-s2.0-0025347894 (Pubitemid 20176061)
16. Heydendael V. M. R., Spuls P. I., Opmeer B. C., De Borgie C. A. J. M., Reitsma J. B., Goldschmidt W. F. M., Bossuyt P. M. M., Bos J. D., De Rie M. A., Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. New England Journal of Medicine 2003 349 7 658 665 2-s2.0-0042625001 10.1056/NEJMoa021359 (Pubitemid 36975998)
17. Flytström I., Stenberg B., Svensson Å., Bergbrant I.-M., Methotrexate versus ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial. British Journal of Dermatology 2008 158 1 116 121 2-s2.0-36849031709 10.1111/j.1365-2133.2007.08284.x (Pubitemid 350221914)
18. Faerber L., Braeutigam M., Weidinger G., Mrowietz U., Christophers E., Schulze H. J., Mahrle G., Meffert H., Drechsler S., Cyclosporine in severe psoriasis: results of a meta-analysis in 579 patients. American Journal of Clinical Dermatology 2001 2 1 41 47 2-s2.0-0035043206 (Pubitemid 32405893)
19. Finzi A. F., Individualized short-course cyclosporin therapy in psoriasis. British Journal of Dermatology 1996 135 48, supplement 31 34 2-s2.0-0029813029 (Pubitemid 26294728)
20. Koo J., Neoral in psoriasis therapy: toward a new perspective. International Journal of Dermatology 1997 36 1 25 29 2-s2.0-0031473085 (Pubitemid 28060184)
21. Yoon H. S., Youn J. I., A comparison of two cyclosporine dosage regimens for the treatment of severe psoriasis. Journal of Dermatological Treatment 2007 18 5 286 290 2-s2.0-35148896887 10.1080/09546630701418747 (Pubitemid 47537259)
22. Schopf R. E., Hultsch T., Lotz J., Bräutigam M., Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A. Journal of the European Academy of Dermatology and Venereology 1998 11 3 234 239 2-s2.0-0032420326 10.1016/S0926-9959(98)00084-1 (Pubitemid 29010429)
23. Touw C. R., Hakkaart-Van Roijen L., Verboom P., Paul C., Rutten F. F., Finlay A. W., Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporine. British Journal of Dermatology 2001 144 5 967 972
24. Colombo D., Flori L., Altomare G., Aste N., Sgarbi S., Clinical outcome evaluation following cyclosporine a treatment in moderate to severe psoriasis: a retrospective study. International Journal of Immunopathology and Pharmacology 2010 23 1 363 367 2-s2.0-77951732288
25. Okubo Y., Natsume S., Usui K., Amaya M., Tsuboi R., Low-dose, short-term ciclosporin (Neoral) therapy is effective in improving patients' quality of life as assessed by Skindex-16 and GHQ-28 in mild to severe psoriasis patients. Journal of Dermatology 2011 38 5 465 472 2-s2.0-79955407534 10.1111/j.1346-8138. 2010.01041.x
26. Zachariae H., Abrams B., Bleehen S. S., Bräutigam M., Burrows D., Ettelt M. J., Fry L., Happle R., Haustein U. F., Ganslandt J., Jung E. G., Knop J., Kühne K. H., Mellein B., Mørk N. J., Rogers S., Schmidt A.-G., Schopf R. E., Sumner M., Taube K. M., Weidinger G., Wurdel C., Zahn E., Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability. Dermatology 1998 196 2 231 236 2-s2.0-0031933038 10.1159/000017880 (Pubitemid 28138417)
27. Kusaba T., Konno Y., Hatta S., Fujino T., Yasuda T., Miura H., Sasaki H., Okabayashi J., Murao M., Sakurada T., Imai G., Shirai S., Kuboshima S., Shima Y., Ogimoto G., Sato T., Masuhara K., Kimura K., More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome. Pharmacotherapy 2005 25 1 52 58 2-s2.0-19944429269 10.1592/phco.25.1.52.55617 (Pubitemid 40054033)
28. Umezawa Y., Mabuchi T., Ozawa A., Preprandial versus postprandial pharmacokinetics of cyclosporine in patients with psoriasis. International Journal of Dermatology 2007 46 8 880 882 2-s2.0-34547492277 10.1111/j.1365-4632. 2007.03134.x (Pubitemid 47162797)
29. Hashizume H., Ito T., Yagi H., Takigawa M., Kageyama H., Furukawa F., Hata M., Shirahama S., Tanaka M., Higashishiba T., Machida H., Tsushima T., Matsushita K., Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris. Journal of Dermatology 2007 34 7 430 434 2-s2.0-34250751223 10.1111/j.1346-8138.2007.00305.x (Pubitemid 46956586)
30. Gisondi P., Del Giglio M., Di Francesco V., Zamboni M., Girolomoni G., Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. American Journal of Clinical Nutrition 2008 88 5 1242 1247 2-s2.0-55849143623 10.3945/ajcn.2008.26427
31. Powles A. V., Hardman C. M., Porter W. M., Cook T., Hulme B., Fry L., Renal function after 10 years' treatment with cyclosporin for psoriasis. British Journal of Dermatology 1998 138 3 443 449 2-s2.0-0031943069 10.1046/j.1365-2133.1998.02122.x (Pubitemid 28145512)
32. Shintani Y., Kaneko N., Furuhashi T., Saito C., Morita A., Safety and efficacy of a fixed-dose cyclosporin microemulsion (100 mg) for the treatment of psoriasis. Journal of Dermatology 2011 38 10 966 972 2-s2.0-80053277173 10.1111/j.1346-8138.2011.01228.x
33. Fradin M. S., Ellis C. N., Voorhees J. J., Rapid response of von Zumbusch psoriasis to cyclosporine. Journal of the American Academy of Dermatology 1990 23 5 I 925 926 2-s2.0-0025048103 (Pubitemid 20366105)
34. Griffiths C. E. M., Dubertret L., Ellis C. N., Finlay A. Y., Finzi A. F., Ho V. C., Johnston A., Katsambas A., Lison A.-E., Naeyaert J. M., Nakagawa H., Paul C., Vanaclocha F., Ciclosporin in psoriasis clinical practice: an international consensus statement. British Journal of Dermatology 2004 150 67, supplement 11 23 2-s2.0-3142619217 (Pubitemid 38903574)
35. Studio Italiano Multicentrico nella Psoriasi (SIMPSO), Short and long-term considerations conserning the management of claque psoriasis with low-dose cyclosporine. Dermatology 1993 187 1 19 29
36. Mrowietz U., Färber L., Henneicke-Von Zepelin H.-H., Bachmann H., Welzel D., Christophers E., Hums H., Prifert P., Albrecht A., Borchers B., Czarnetzki C., Knoll K., Meffert M., Stojanow S., Altmeyer A., El-Gammal E.-G., Kreysel K., Lindenblatt L., Tronnier T., Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: results of a multicenter study. Journal of the American Academy of Dermatology 1995 33 3 470 475 2-s2.0-0029097190 10.1016/0190-9622(95)91393-9
37. Ho V. C. Y., Griffiths C. E. M., Berth-Jones J., Papp K. A., Vanaclocha F., Dauden E., Beard A., Puvanarajan L., Paul C., Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study. Journal of the American Academy of Dermatology 2001 44 4 643 651 2-s2.0-0035094870 10.1067/mjd.2001.112400 (Pubitemid 32249523)
38. Hakkaart-Van Roijen L., Verboom P., Redekop W. K., Touw K. R., Rutten F. F. H., The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasis. PharmacoEconomics 2001 19 5 599 608 2-s2.0-0035001558 (Pubitemid 32488746)
39. Zachariae H., Kragballe K., Hansen H. E., Marcussen N., Olsen S., Renal biopsy findings in long-term cyclosporin treatment of psoriasis. British Journal of Dermatology 1997 136 4 531 535 2-s2.0-0030888406 (Pubitemid 27160326)
40. Menter A., Korman N. J., Elmets C. A., Feldman S. R., Gelfand J. M., Gordon K. B., Gottlieb A. B., Koo J. Y. M., Lebwohl M., Lim H. W., Van Voorhees A. S., Beutner K. R., Bhushan R., Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. Journal of the American Academy of Dermatology 2009 61 3 451 485 2-s2.0-68949149916 10.1016/j.jaad.2009.03.027
41. Ryan C., Amor K. T., Menter A., The use of cyclosporine in dermatology-part II. Journal of the American Academy of Dermatology 2010 63 6 949 972 2-s2.0-78649382560 10.1016/j.jaad.2010.02.062
42. Pathirana D., Ormerod A. D., Saiag P., European S3-Guidelines on the systemic treatment of psoriasis vulgaris. Journal of the European Academy of Dermatology and Venereology 2010 23 2, supplement 1 70
43. Maza A., Montaudié H., Sbidian E., Gallini A., Aractingi S., Aubin F., Bachelez H., Cribier B., Joly P., Jullien D., Le Maître M., Misery L., Richard M.-A., Ortonne J.-P., Paul C., Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. Journal of the European Academy of Dermatology and Venereology 2011 25 2 19 27 2-s2.0-79952549095 10.1111/j.1468-3083.2011. 03992.x
44. Chaidemenos G. C., Mourellou O., Avgoustinaki N., Papakonstantinou M., Karakatsanis G., Katsambas A., Intermittent versus continuous 1-year cyclosporin use in chronic plaque psoriasis. Journal of the European Academy of Dermatology and Venereology 2007 21 9 1203 1208 2-s2.0-34548735272 10.1111/j.1468-3083. 2007.02226.x (Pubitemid 47423408)
45. Ohtsuki M., Nakagawa H., Sugai J., Ozawa A., Ohkido M., Nakayama J., Hanada J., Morimoto Y., Jimbow K., Horikoshi T., Kitahara H., Tamaki K., Urabe K., Hori Y., Long-term continuous versus intermittent cyclosporin: therapy for psoriasis. Journal of Dermatology 2003 30 4 290 298 2-s2.0-10744222491 (Pubitemid 36554137)
46. Shupack J., Abel E., Bauer E., Brown M., Drake L., Freinkel R., Guzzo C., Koo J., Levine N., Lowe N., McDonald C., Margolis D., Stiller M., Wintroub B., Bainbridge C., Evans S., Hilss S., Mietlowski W., Winslow C., Birnbaum J. E., Cyclosporine as maintenance therapy in patients with severe psoriasis. Journal of the American Academy of Dermatology 1997 36 3 423 432 2-s2.0-0030891982 10.1016/S0190-9622(97)80219-8 (Pubitemid 27131966)
47. Ellis C. N., Fradin M. S., Hamilton T. A., Voorhees J. J., Duration of remission during maintenance cyclosporine therapy for psoriasis: relationship to maintenance dose and degree of improvement during initial therapy. Archives of Dermatology 1995 131 7 791 795 2-s2.0-0029044672 10.1001/archderm.131.7.791
48. Goodman M. M., White G. M., McCormick A., McCullough J., Weinstein G., Cyclosporine therapy for psoriasis: a cell cycle-derived dosing schedule. Journal of the American Academy of Dermatology 1992 27 4 594 598 2-s2.0-0026655830
49. Vena G. A., Cassano N., Galluccio A., Loconsole F., Coviello C., Fai D., Dattola S., Ferrari A., Ligori P., Lopreiato R., Pelle S., Postorino M. F., Ricciuti F., Valenti G., Malvindi C., Lui P., Evaluation of the efficacy and tolerability of a new intermittent treatment regimen with cyclosporin A in severe psoriasis. Giornale Italiano di Dermatologia e Venereologia 2005 140 5 575 582 2-s2.0-33745360229 (Pubitemid 43942772)
50. Vena G. A., Coviello C., Foti C., Curatoli G., Mastrolonardo M., Ciclosporina A nella psoriasi: mantenimento dell'efficacia con somministrazione intervallata. Chronica Dermatologica 1994 4 4 639 645
51. Ioannides D., Mattheou-Vakali G., Lazaridou E., Batsios K., Panagiotidou D., Minas A., Maintenance treatment with cyclosporin in psoriasis. British Journal of Dermatology 1997 136 3 470 471 2-s2.0-0031044450
52. Colombo D., Cassano N., Altomare G., Giannetti A., Vena G. A., Psoriasis relapse evaluation with week-end cyclosporine A treatment: results of a randomized, double-blind, multicenter study. International Journal of Immunopathology and Pharmacology 2010 23 4 1143 1152 2-s2.0-79953019348
53. Van De Kerkhof P. C. M., Therapeutic strategies: rotational therapy and combinations. Clinical and Experimental Dermatology 2001 26 4 356 361 2-s2.0-0035725710 10.1046/j.1365-2230.2001.00829.x (Pubitemid 34204351)
54. Lebwohl M., Ali S., Treatment of psoriasis-part 2. Systemic therapies. Journal of the American Academy of Dermatology 2001 45 5 649 661 2-s2.0-0034753878 10.1067/mjd.2001.117047 (Pubitemid 33032559)
55. Muellenhoff M. W., Koo J. Y., Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology. Journal of Dermatological Treatment 2012 23 4 290 304
56. Naldi L., Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies. Clinics in Dermatology 2010 28 1 88 92 2-s2.0-71749099998 10.1016/j. clindermatol.2009.03.003
57. Calzavara-Pinton P., Leone G., Venturini M., Sala R., Colombo D., La Parola I. L., Sitzia N., Ferraro C., Picardo M., A comparative non randomized study of narrow-band (NB) (312 ± 2 nm) UVB phototherapy versus sequential therapy with oral administration of low-dose Cyclosporin a and NB-UVB phototherapy in patients with severe psoriasis vulgaris. European Journal of Dermatology 2005 15 6 470 473 2-s2.0-28244441151 (Pubitemid 41711908)
58. Roenigk H. H. Jr., Acitretin combination therapy. Journal of the American Academy of Dermatology 1999 41 3 S18 S21 2-s2.0-0032831629
59. Koo J., Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results. Journal of the American Academy of Dermatology 1999 41 3 S25 S28 2-s2.0-0032835816 (Pubitemid 29416465)
60. Lebwohl M., Menter A., Koo J., Feldman S. R., Combination therapy to treat moderate to severe psoriasis. Journal of the American Academy of Dermatology 2004 50 3 416 430 2-s2.0-1542344331 10.1016/j.jaad.2002.12.002 (Pubitemid 38316135)
61. Webber I. R., Back D. J., Effect of etretinate on cyclosporin metabolism in vitro. British Journal of Dermatology 1993 128 1 42 44 2-s2.0-0027396810 10.1111/j.1365-2133.1993.tb00145.x (Pubitemid 23030146)
62. Brechtel B., Wellenreuther U., Toppe E., Czarnetzki B. M., Combination of etretinate with cyclosporine in the treatment of severe recalcitrant psoriasis. Journal of the American Academy of Dermatology 1994 30 6 1023 1024 2-s2.0-0028234396 (Pubitemid 24166578)
63. Kuijpers A. L. A., Van Dooren-Greebe R. J., Van De Kerkhof P. C. M., Failure of combination therapy with acitretin and cyclosporin A in 3 patients with euythrodermic psoriasis. Dermatology 1997 194 1 88 90 2-s2.0-0031014076 (Pubitemid 27047346)
64. Kokelj F., Plozzer C., Torsello P., Trevisan G., Efficacy of cyclosporine plus etretinate in the treatment of erythrodermic psoriasis (three case reports). Journal of the European Academy of Dermatology and Venereology 1998 11 2 177 179 2-s2.0-0031714113 10.1016/S0926-9959(98)00060-9 (Pubitemid 28445044)
65. Mazzanti G., Coloni L., De Sabbata G., Paladini G., Methotrexate and cyclosporin combined therapy in severe psoriatic arthritis. A pilot study. Acta Dermato-Venereologica 1994 186, supplement 116 117 2-s2.0-0028313231 (Pubitemid 24208176)
66. Tugwell P., Pincus T., Yocum D., Stein M., Gluck O., Kraag G., Mckendry R., Tesser J., Baker P., Wells G., Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. New England Journal of Medicine 1995 333 3 137 141 2-s2.0-0029022389 10.1056/NEJM199507203330301
67. Stein C. M., Pincus T., Yocum D., Tugwell P., Wells G., Gluck O., Kraag G., Torley H., Tesser J., McKendry R., Brooks R. H., Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. Arthritis and Rheumatism 1997 40 10 1843 1851 2-s2.0-15144356729 10.1002/art.1780401018 (Pubitemid 27452536)
68. Daly M., Alikhan A., Armstrong A. W., Combination systemic therapies in psoriatic arthritis. Journal of Dermatological Treatment 2011 22 5 276 284 2-s2.0-80053073164 10.3109/09546631003801601
69. Fraser A. D., Van Kuijk A. W. R., Westhovens R., Karim Z., Wakefield R., Gerards A. H., Landewé R., Steinfeld S. D., Emery P., Dijkmans B. A. C., Veale D. J., A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis. Annals of the Rheumatic Diseases 2005 64 6 859 864 2-s2.0-21144451096 10.1136/ard.2004.024463 (Pubitemid 40733909)
70. Clark C. M., Kirby B., Morris A. D., Davison S., Zaki I., Emerson R., Saihan E. M., Chalmers R. J. G., Barker J. N. W. N., Allen B. R., Griffiths C. E. M., Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis. British Journal of Dermatology 1999 141 2 279 282 2-s2.0-0032769437 10.1046/j.1365-2133.1999.02976.x (Pubitemid 29397996)
71. Aydin F., Canturk T., Senturk N., Turanli A. Y., Methotrexate and ciclosporin combination for the treatment of severe psoriasis. Clinical and Experimental Dermatology 2006 31 4 520 524 2-s2.0-33744461034 10.1111/j.1365-2230.2006.02153.x (Pubitemid 43806583)
72. Mohanan S., Ramassamy S., Chandrashekar L., Thappa D. M., A retrospective analysis of combination methotrexate-cyclosporine therapy in moderate-severe psoriasis. Journal of Dermatological Treatment 2013
73. Korstanje M. J., Van Breda Vriesman C. J. P., Van De Staak W. J. B. M., Cyclosporine and methotrexate: a dangerous combination. Journal of the American Academy of Dermatology 1990 23 2 320 321 2-s2.0-0025126588 (Pubitemid 20259933)
74. Wong K. C., Georgouras K., Low dose cyclosporin A and methotrexate in the treatment of psoriasis. Acta Dermato-Venereologica 1999 79 1 87 2-s2.0-0033053513 10.1080/000155599750011831 (Pubitemid 29079342)
75. Gottlieb S. L., Heftler N. S., Gilleaudeau P., Johnson R., Vallat V. P., Wolfe J., Gottlieb A. B., Krueger J. G., Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study. Journal of the American Academy of Dermatology 1995 33 4 637 645 2-s2.0-0029050319
76. Grossman R. M., Thivolet J., Claudy A., Souteyrand P., Guilhou J. J., Thomas P., Amblard P., Belaich S., De Belilovsky C., De la Brassinne M., Martinet C., Bazex J. A., Beylot C., Combemale P., Lambert D., Ostojic A., Denoeux J. P., Lauret P., Vaillant L., A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: results of a multicenter placebo- controlled study. Journal of the American Academy of Dermatology 1994 31 1 68 74 2-s2.0-0028237398 (Pubitemid 24198166)
77. Vena G. A., Galluccio A., Pezza M., Vestita M., Cassano N., Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study. Journal of Dermatological Treatment 2012 23 4 255 260
78. Cassano N., Vena G. A., Cyclosporine in the era of biologics: a mini-review with special emphasis on the possible use in combination with biologics for psoriasis. Clinical Dermatology 2013 1 1 15 18
79. D'Angelo S., Cutro M. S., Lubrano E., Leccese P., Mennillo G. A., Ferrara N., Olivieri I., Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis. Annals of the Rheumatic Diseases 2010 69 5 934 935 2-s2.0-77951600234 10.1136/ard.2009.119446
80. Atzeni F., Boccassini L., Antivalle M., Salaffi F., Sarzi-Puttini P., Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot study. Annals of the Rheumatic Diseases 2011 70 4 712 714 2-s2.0-79952347225 10.1136/ard.2010. 130864
81. Karanikolas G. N., Koukli E.-M., Katsalira A., Arida A., Petrou D., Komninou E., Fragiadaki K., Zacharioudaki A., Lasithiotakis I., Giavri E., Vaiopoulos G., Sfikakis P. P., Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial. Journal of Rheumatology 2011 38 11 2466 2474 2-s2.0-80155181444 10.3899/jrheum.110242
82. Vena G. A., Mastrandrea V., Battaglini S., Loconsole F., Buquicchio R., Cassano N., Combination of etanercept and twice-weekly administration of cyclosporin in psoriasis unsatisfactorily controlled by etanercept monotherapy: a retrospective analysis. European Journal of Inflammation 2012 10 2 239 242